Blinatumomab Administration in Pediatric B-Lineage ALL: Expert Recommendations From the Children’s Oncology Group

20250 citationsJournal Articlegreen Open Access

Authors

Holly R. Kubaney

Kathleen Montgomery · Controlled Chemicals (United States)

Lauren Guidry · State Administration of Foreign Experts Affairs

Maki Okada · University of Agriculture

Katelyn Oranges · Orange (Poland)

Shelby Smith · Cleveland Community College

Megan Elizabeth Wegter · St. Elizabeth Healthcare

Abstract

Engaging patients, families, and clinicians promotes care transitions between inpatient and outpatient settings and minimizes complications. Ongoing institutional commitment to monitor and capture emerging trends in blinatumomab administration can inform future optimal care practices.

Topics & Keywords

Acute Lymphoblastic Leukemia research Childhood Cancer Survivors' Quality of Life Chronic Myeloid Leukemia Treatments

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Clinical journal of oncology nursing

Volume 29, Issue 4, pp. 303-312

DOI: 10.1188/25.cjon.303-312

Field-Weighted Citation Impact: 0.00